Wedge Capital Management L L P United Therapeutics Corp Transaction History

Wedge Capital Management L L P

  • $6.04 Billion
  • Q1 2024

A detailed history of Wedge Capital Management L L P transactions in United Therapeutics Corp stock. As of the latest transaction made, Wedge Capital Management L L P holds 170,549 shares of UTHR stock, worth $54.1 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
170,549
Holding current value
$54.1 Million
% of portfolio
0.65%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
BUY
$210.76 - $249.51 $35.9 Million - $42.6 Million
170,549 New
170,549 $39.2 Million
Q4 2022

Jan 17, 2023
SELL
$205.95 - $280.43 $4.6 Million - $6.27 Million
-22,343 Reduced 13.5%
143,163 $39.8 Million
Q3 2022

Oct 13, 2022
BUY
$203.3 - $244.17 $1.11 Million - $1.34 Million
5,478 Added 3.42%
165,506 $34.7 Million
Q2 2022

Jul 11, 2022
SELL
$174.81 - $241.14 $3.08 Million - $4.25 Million
-17,635 Reduced 9.93%
160,028 $37.7 Million
Q1 2022

Apr 12, 2022
BUY
$166.16 - $213.96 $2.59 Million - $3.33 Million
15,564 Added 9.6%
177,663 $31.9 Million
Q4 2021

Jan 24, 2022
BUY
$184.32 - $216.08 $712,212 - $834,933
3,864 Added 2.44%
162,099 $35 Million
Q3 2021

Oct 14, 2021
SELL
$179.86 - $214.88 $4.63 Million - $5.53 Million
-25,758 Reduced 14.0%
158,235 $29.2 Million
Q2 2021

Jul 14, 2021
SELL
$170.47 - $211.93 $960,257 - $1.19 Million
-5,633 Reduced 2.97%
183,993 $33 Million
Q1 2021

Apr 12, 2021
SELL
$153.94 - $174.85 $1.46 Million - $1.66 Million
-9,490 Reduced 4.77%
189,626 $31.7 Million
Q4 2020

Jan 08, 2021
SELL
$101.87 - $151.79 $5.77 Million - $8.59 Million
-56,611 Reduced 22.14%
199,116 $30.2 Million
Q3 2020

Oct 08, 2020
SELL
$99.9 - $121.13 $3.11 Million - $3.77 Million
-31,128 Reduced 10.85%
255,727 $25.8 Million
Q2 2020

Jul 10, 2020
BUY
$92.74 - $125.82 $26.6 Million - $36.1 Million
286,855 New
286,855 $34.7 Million
Q2 2019

Aug 01, 2019
SELL
$76.06 - $120.81 $25.5 Million - $40.5 Million
-335,155 Closed
0 $0
Q1 2019

May 02, 2019
BUY
$107.15 - $126.84 $4.26 Million - $5.04 Million
39,737 Added 13.45%
335,155 $39.3 Million
Q4 2018

Jan 31, 2019
BUY
$101.4 - $128.73 $2.54 Million - $3.23 Million
25,075 Added 9.28%
295,418 $32.2 Million
Q3 2018

Nov 01, 2018
SELL
$113.81 - $129.46 $340,291 - $387,085
-2,990 Reduced 1.09%
270,343 $34.6 Million
Q2 2018

Jul 31, 2018
SELL
$101.14 - $118.31 $4.81 Million - $5.63 Million
-47,559 Reduced 14.82%
273,333 $30.9 Million
Q1 2018

May 01, 2018
SELL
$107.21 - $151.94 $400,858 - $568,103
-3,739 Reduced 1.15%
320,892 $36.1 Million
Q4 2017

Jan 31, 2018
BUY
$118.58 - $151.28 $37.1 Million - $47.4 Million
313,143 Added 2725.83%
324,631 $48 Million
Q3 2017

Oct 31, 2017
BUY
$114.6 - $136.81 $1.32 Million - $1.57 Million
11,488
11,488 $1.35 Million

Others Institutions Holding UTHR

# of Institutions
561
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email